In invasive breast carcinoma, SERCA3 expression levels are significantly decreased compared with that in normal patients, indicating that SERCA3 expression is inversely associated with tumor differentiation and the degree of aggressiveness/malignancy of ductal carcinoma [18,24,25,26,27,28]. The gene discussed is ATP2A3; the disease is breast ductal adenocarcinoma.